1. Artemisia annua products in Canada not linked to liver injury

   News item 10 April 2021 Pages: 1 - 1

2. AstraZeneca COVID-19 vaccine: EMA continues review of rare blood clots

   News item 10 April 2021 Pages: 2 - 2

3. Bendamustine-related non-melanoma skin cancer and PML

   News item 10 April 2021 Pages: 3 - 3

4. Falsified COVID-19 vaccine recently identified in Mexico

   News item 10 April 2021 Pages: 4 - 4

5. FDA warning companies not to sell unapproved cannabidiol products

   News item 10 April 2021 Pages: 5 - 5

6. Medsafe publishes consultation outcomes regarding paracetamol

   News item 10 April 2021 Pages: 6 - 6

7. Anti-PD1-based immunotherapy: risk of delayed immune-related AEs

   Clinical study 10 April 2021 Pages: 7 - 7

8. AstraZeneca COVID-19 vaccine: no increased rate of VTE

   Clinical study 10 April 2021 Pages: 8 - 8

9. Other adverse reaction research

   News item 10 April 2021 Pages: 9 - 9

10. Adalimumab

    Case report 10 April 2021 Pages: 10 - 10

11. Adalimumab

    Case report 10 April 2021 Pages: 11 - 11

12. Afatinib/gefitinib

    Case report 10 April 2021 Pages: 12 - 12

13. Alectinib

    Case report 10 April 2021 Pages: 13 - 13

14. Alemtuzumab

    Case report 10 April 2021 Pages: 14 - 14

15. Alemtuzumab

    Case report 10 April 2021 Pages: 15 - 15

16. Alemtuzumab/dimethyl fumarate

    Case report 10 April 2021 Pages: 16 - 16

17. Alendronic acid/ibandronic acid/risedronic acid

    Case report 10 April 2021 Pages: 17 - 17

18. Alprazolam/tramadol

    Case report 10 April 2021 Pages: 18 - 18

19. Alteplase

    Case report 10 April 2021 Pages: 19 - 19

20. Aluminium poisoning

    Case report 10 April 2021 Pages: 20 - 20

21. Amiodarone

    Case report 10 April 2021 Pages: 21 - 21

22. Amiodarone

    Case report 10 April 2021 Pages: 22 - 22

23. Amiodarone

    Case report 10 April 2021 Pages: 23 - 23

24. Amiodarone/bisoprolol/carvedilol

    Case report 10 April 2021 Pages: 24 - 24

25. Amiodarone/lidocaine

    Case report 10 April 2021 Pages: 25 - 25

26. Amiodarone/norepinephrine/tocilizumab

    Case report 10 April 2021 Pages: 26 - 26

27. Amiodarone/propofol

    Case report 10 April 2021 Pages: 27 - 27

28. Amiodarone/sodium-perchlorate

    Case report 10 April 2021 Pages: 28 - 28

29. Amlodipine

    Case report 10 April 2021 Pages: 29 - 29

30. Amlodipine/phenytoin

    Case report 10 April 2021 Pages: 30 - 30

31. Amoxicillin/clavulanic acid

    Case report 10 April 2021 Pages: 31 - 31

32. Amoxicillin/nonsteroidal-anti-inflammatories

    Case report 10 April 2021 Pages: 32 - 32

33. Amphotericin-b-liposomal

    Case report 10 April 2021 Pages: 33 - 33

34. Anakinra/cyclophosphamide/rituximab/steroids

    Case report 10 April 2021 Pages: 34 - 34

35. Anti-inflammatories/azathioprine

    Case report 10 April 2021 Pages: 35 - 35

36. Antiarrhythmics

    Case report 10 April 2021 Pages: 36 - 36

37. Antiarrhythmics/pilsicainide/thiamylal sodium

    Case report 10 April 2021 Pages: 37 - 37

38. Antibacterials/antiepileptic drugs/ibuprofen

    Case report 10 April 2021 Pages: 38 - 38

39. Antibacterials/antituberculars

    Case report 10 April 2021 Pages: 39 - 39

40. Antibacterials/antivirals

    Case report 10 April 2021 Pages: 40 - 40

41. Antibacterials/bronchodilators/anticholinergics

    Case report 10 April 2021 Pages: 41 - 41

42. Antibacterials/heparin

    Case report 10 April 2021 Pages: 42 - 42

43. Antihyperlipidaemics

    Case report 10 April 2021 Pages: 43 - 43

44. Antineoplastics

    Case report 10 April 2021 Pages: 44 - 44

45. Antineoplastics

    Case report 10 April 2021 Pages: 45 - 45

46. Antineoplastics

    Case report 10 April 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 10 April 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 10 April 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 10 April 2021 Pages: 49 - 49

50. Antineoplastics

    Case report 10 April 2021 Pages: 50 - 50